Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 May 2018

The National Research Foundation (NRF) ratings are considered the benchmark for research excellence. This year the University of the Free State (UFS) has 17 newly NRF-rated researchers. This brings the total number of NRF-rated researchers at UFS to 160.
 
NRF ratings are allocated based on a researcher’s recent research outputs and impact as perceived by national and international peer reviewers. The rating system encourages researchers to publish high-quality research papers in journals of high impact and to publish books through reputed academic publishers. The NRF rating system is a valuable tool for benchmarking the quality of our researchers against the best in the world.

Research at the heart of the UFS
Prof Francis Petersen, Rector and Vice-Chancellor, has indicated that the UFS provides significant support to researchers to apply for new NRF ratings or to re-apply for rating. These initiatives include the mock NRF rating panels managed by the Prestige Scholars Programme (PSP), evaluation of individual research outputs and recommendations on timely applying for rating, and improvements on rating applications by a panel consisting of internal and external members. These initiatives are bearing fruit by increasing the number of rated researchers who will transform the research profile and increase the diversity of UFS researchers.
Cultivating the best researchers.

According to Eleanor van der Westhuizen, from Research Development: “The rating of individuals is based primarily on the quality and impact of their research outputs over the past eight years, taking into consideration the evaluation made by local and international peers. It identifies researchers who count among the leaders in their fields of expertise and gives recognition to those who have a sustained production of high-quality research outputs. Several South African universities use the outcomes of the NRF evaluation and rating process to position themselves as research-intensive institutions, while others such as the UFS provide incentives for their staff members to acquire and maintain a rating.”

Cream of the crop
The UFS has also upped the ante with regard to its total number of NRF-rated researchers during the latest rating and evaluation, with an increase from 149 to 160 rated researchers in 2018.
 
Prof Heidi Hudson, Dean of Humanities, received an NRF B-rating, which brings the total of B-rated researchers to six. Other B-rated researchers incude Prof Johann Meyer (Mathematics), Prof Fanie Snyman and Prof Francois Tolmie (Theology), Prof Felicity Burt (Medical Microbiology) and Prof Andre Roodt (Chemistry). A total number of 10 new C-ratings and six new Y-ratings were achieved during the 2018 evaluation process.

“NRF-rating is indicative of the university’s drive to enhance its research profile nationally and internationally. Congratulations to all the scientists and scholars who received a rating in 2017. I am thankful to our academics for their commitment to the rating process,” said Prof Corli Witthuhn, Vice-Rector: Research at the UFS.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept